Semaglitude and
Tirzepitide –
GLP-1 receptor agonists are showing promise not only in managing diabetes and weight loss but also in potentially extending healthy lifespan by addressing several key aspects of aging. By improving metabolic health, reducing inflammation, and protecting against age-related diseases, these medications offer a multifaceted approach to anti-aging. Their ability to impact fundamental aging processes, such as mitochondrial function and inflammation, makes them a compelling area of research in the quest for therapies that promote longevity.